China Pharmaceuticals: Announcement on Subsidiaries Obtaining Drug Registration Approvals
China Pharmaceutical: 2024 Fifth Extraordinary General Meeting of Shareholders Meeting Information
Announcement on the subsidiary obtaining approval for drug registration
2024 Fifth Extraordinary General Meeting of Shareholders Meeting Materials
China Pharmaceutical: Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementary Applications
Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementation Applications
Announcement on the subsidiary\'s drug passing the generic drug consistency evaluation
Announcement on the progress of important shareholding companies planning to change the actual controller
China Pharmaceutical Investor Relations Activity Record Form
Announcement of Resolutions of the 21st Meeting of the 9th Board of Directors
General Technology Liaoning Pharmaceutical Co., Ltd. Shareholders\' Total Equity Value Asset Assessment Report
General Technology Liaoning Pharmaceutical Co., Ltd. 2023 Audit Report
Related Party Fund Transaction Management System (2024 Revision)
Announcement on renewal of office buildings and related transactions
Notice on the change of accounting firm
Announcement on the acquisition of related-party assets
Notice on convening the 5th Extraordinary General Meeting of Shareholders in 2024
Announcement on the subsidiary obtaining approval for drug registration
Announcement on the subsidiary obtaining approval for drug registration
Announcement on the subsidiary\'s drug passing the generic drug consistency evaluation
No Data